Inhalable Particles for “Pincer Therapeutics” Targeting Nitazoxanide as Bactericidal and Host-Directed Agent to Macrophages in a Mouse Model of Tuberculosis

• Published in: Molecular pharmaceutics 2016-09, Vol.13 (9), p.3247-3255
• Main Authors: Gupta, Anuradha, Meena, Jairam, Sharma, Deepak, Gupta, Pushpa, Gupta, Umesh Dutta, Kumar, Sadan, Sharma, Sharad, Panda, Amulya K, Misra, Amit
• Format: Article
• Language: English
• Subjects: Administration, Inhalation; Animals; Antitubercular Agents - administration & dosage; Antitubercular Agents - therapeutic use; Autophagy - drug effects; Cell Line; Humans; Isoniazid - administration & dosage; Isoniazid - therapeutic use; Macrophages - drug effects; Male; Mice; Radiotherapy Planning, Computer-Assisted; Rifabutin - administration & dosage; Rifabutin - therapeutic use; Thiazoles - administration & dosage; Thiazoles - therapeutic use; Tuberculosis - drug therapy; Tuberculosis - metabolism
• ISSN: 1543-8384; 1543-8392
• DOI: 10.1021/acs.molpharmaceut.6b00459

Nitazoxanide (NTZ) has moderate mycobactericidal activity and is also an inducer of autophagy in mammalian cells. High-payload (40–50% w/w) inhalable particles containing NTZ alone or in combination with antituberculosis (TB) agents isoniazid (INH) and rifabutin (RFB) were prepared with high incorporation efficiency of 92%. In vitro drug release was corrected for drug degradation during the course of study and revealed first-order controlled release. Particles were efficiently taken up in vitro by macrophages and maintained intracellular drug concentrations at one order of magnitude higher than NTZ in solution for 6 h. Dose-dependent killing of Mtb and restoration of lung and spleen architecture were observed in experimentally infected mice treated with inhalations containing NTZ. Adjunct NTZ with INH and RFB cleared culturable bacteria from the lung and spleen and markedly healed tissue architecture. NTZ can be used in combination with INH-RFB to kill the pathogen and heal the host.